Gregory Kalemkerian, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    lung cancer
    Date added:
    06/15/2023
    Date updated:
    06/15/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Blueprint
    Topic:
    lung cancer
    Date added:
    06/15/2023
    Date updated:
    06/15/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Takeda
    Topic:
    lung cancer
    Date added:
    06/15/2023
    Date updated:
    06/15/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Cullinan
    Topic:
    lung cancer
    Date added:
    06/15/2023
    Date updated:
    06/15/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Daiichi
    Topic:
    lung cancer
    Date added:
    06/15/2023
    Date updated:
    06/15/2023
Return to 2023 Midwest Precision Oncology Symposium